CAR-T Therapy Global Market Report 2022

May 2022| TBR754D| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Monotherapy; Combination Therapy
2) By Target Antigen: CD19; CD22; Other Target Antigens
3) By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Other Applications
Covering: Novartis AG; Kite Pharma; Pfizer inc.; Juno Therapeutics; Celgene Corporation; CARsgen Therapeutics

CAR-T Therapy Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T therapy market.

This report focuses on CAR-T therapy market which is experiencing strong growth. The report gives a guide to the CAR-T therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the CAR-T therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The CAR-T therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider CAR-T therapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The CAR-T therapy market section of the report gives context. It compares the CAR-T therapy market with other segments of the CAR-T therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, CAR-T therapy indicators comparison.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Type: Monotherapy; Combination Therapy
  • By Target Antigen: CD19; CD22; Other Target Antigens
  • By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Other Applications

Companies Mentioned: Novartis AG; Kite Pharma; Pfizer Inc; Juno Therapeutics; Celgene Corporation

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3 : Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5 : Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6 : Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13 : Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14 : South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15 : Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16 : UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17 : Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18 : France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19 : Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20 : Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21 : North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22 : USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23 : South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24 : Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25 : Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26 : Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27 : Novartis AG Financial Performance
  • Table 28 : Kite Pharma Financial Performance
  • Table 29 : Pfizer Inc Financial Performance
  • Table 30 : Juno Therapeutics Financial Performance
  • Table 31 : Celgene Corporation Financial Performance
  • Figure 1 : Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3 : Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4 : Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5 : Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6 : Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Asia-Pacific, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : China, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : India, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : Japan, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : Australia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13 : Indonesia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14 : South Korea, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15 : Western Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16 : UK, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17 : Germany, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18 : France, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19 : Eastern Europe, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20 : Russia, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21 : North America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22 : USA, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23 : South America, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24 : Brazil, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25 : Middle East, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26 : Africa, CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27 : Novartis AG Financial Performance
  • Figure 28 : Kite Pharma Financial Performance
  • Figure 29 : Pfizer Inc Financial Performance
  • Figure 30 : Juno Therapeutics Financial Performance
  • Figure 31 : Celgene Corporation Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

CAR-T Therapy Pipeline Analysis Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

  • Date - Sep 2021
  • Code - TBR754C

Including: 1) By Target Antigen: CD19; CD22; BCMA; Others
2) By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others
Covering: Gilead Sciences; Novartis AG

CAR-T Therapy Pipeline Analysis Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research Company provides the strategists, marketers and senior management with ...

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

  • Date - Dec 2020
  • Code - TBR754B

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

Including: By Target Antigen: CD19 Therapy; CD22 Therapy; BCMA Therapy; Others
By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Covering: Gilead Sciences; Novartis AG

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery from ...

CAR-T Therapy Market Global Report 2020-30

  • Date - Apr 2020
  • Code - TBR754A

Including: 1) By Target Antigen: CD19; CD22; Others; 2) By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Others

Covering: Novartis AG; Kite Pharma; Pfizer Inc; Juno Therapeutics; Celgene Corporation

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.